| Title |
Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease
|
|---|---|
| Published in |
PLOS ONE, May 2012
|
| DOI | 10.1371/journal.pone.0036284 |
| Pubmed ID | |
| Authors |
Ph. Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M. Fox |
| Abstract |
Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among patients with stable CAD in routine clinical practice. The goal of the present analysis was to describe HR in such patients, overall and in relation to beta-blocker use, and to describe the determinants of HR. |
Mendeley readers
The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Poland | 1 | 1% |
| Unknown | 97 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 12% |
| Professor | 12 | 12% |
| Student > Master | 10 | 10% |
| Student > Bachelor | 9 | 9% |
| Student > Doctoral Student | 6 | 6% |
| Other | 25 | 26% |
| Unknown | 24 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 38% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 7% |
| Neuroscience | 6 | 6% |
| Agricultural and Biological Sciences | 5 | 5% |
| Biochemistry, Genetics and Molecular Biology | 5 | 5% |
| Other | 8 | 8% |
| Unknown | 30 | 31% |